A CRISPR-Cas9 based genome-wide screening identified novel targets for treating sorafenib-resistant hepatocellular carcinoma: cross-talk of FGF21 and the NRF2 pathway
This study is led by Xiujun Cai (Department of General Surgery, Sir Run-Run Shaw Hospital, Zhejiang University School of Medicine). ...
